HUGE! We get independent data, at the same time ACW produces their phase 1 Data at the premier American Alzheimers conference, THEN the data from both can be published in Scientific Journals. By that stage ACW should be in a Phase 2 trial years ahead of the pack. This really is Cheap in my opinion
Ann: Xanamem & AIBL to showcase Cortisol Hypothesis in Alzheimers-ACW.AX, page-5
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.002(4.88%) |
Mkt cap ! $105.7M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.2¢ | 3.8¢ | $577.7K | 14.34M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1440871 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 482000 | 3 |
View Market Depth
| Last trade - 14.40pm 03/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |